The Expression Levels of RAD51 after Ionizing Radiation in Peripheral Blood Lymphocytes for Evaluation of DNA Repair in Breast Cancer Patients Referred to Ahvaz Golestan Hospital

Document Type : Original Article

Authors

1 Departmant of Medical GeneticAhvaz, Cellular and Molecular Biology Research Center, University of Medical Sciences. Ahvaz, Iran.

2 Departmant of Medical Physics, Ahvaz,University of Medical Sciences, Ahvaz, Iran

3 Department of Radiotherapy & Oncology, Golestan Hospital.

4 Department of Epidemiology& Biostatistics, Diabetes Research Center, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Abstract

Background and Objective: Breast cancer is one of the most common cancers among the women. One of the radical method for treatment of breast cancer is radiotherapy. Radiation induces different responses in cells, including cell cycle checkpoint activation, DNA repair and apoptosis. To check cellular responses and radiosensitivity in each patient, DNA repair mechanism and proteins, as biological markers, can be evaluated. Based on the repair capacity and radiosensitivity of cells in each patient we can design a treatment planning using radiation therapy  The purpose of this study was to evaluate to the radiosensitivity in breast cancer patients to improve treatment planning
Subjects and Methods:A  quantitative  reverse  transcriptase
PCR-based assay for measurement of the expression  level  of  RAD51  in lymphocyte cells for all breast cancer patients and healthy controls. Statistical analyses were performed using SPSS17 software. The relation between the expression level of RAD51and clinical characteristics of patients was analyzed by using the nonparametric Mann-Whitney and Kruskal-Wallis tests.
Results:The expression level of RAD51 significantly up regulated in the peripheral blood lymphocytes of patients (P= 0.006, 8 Fold change) compared to healthy controls. A significantcorrelation between the expression level of RAD51 and HER2/neu (P=0.024) as well as patients age (P= 0.03).
Conclusion: Expression level of RAD51 in lymphocyte cells can be a useful biological marker for evaluation of radiosensitivity in breast cancer.

Keywords


1-Howell A, Sims AH, Ong KR, Harvie MN, Evans DG, Clarke RB. Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions. Nat Clin Pract Oncol 2005;2(12):635-46.
2-Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
3-Tutt A, Yarnold J. Radiobiology of breast cancer. Clin Oncol (R Coll Radiol) 2006;18(3):166-78.
4-Chistiakov DA, Voronova NV, Chistiakov PA. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 2008;47(5):809-24.
5-Duffy MJ, O’Donovan N, Crown J. Use of molecular markers for predicting therapy response in cancer patients. Cancer treat Rev 2011;37(2):151-9.
6-Groth P, Orta ML, Elvers I, Majumder MM, Lagerqvist A, Helleday T. Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation. Nucleic Acids Res 2012;40(14):6585-94.
7-Goodarzi AA, Jeggo PA. Irradiation induced foci (IRIF) as a biomarker for radiosensitivity. Muta Res 2011;736(1-2):39-47.
8-Henning W, Stürzbecher HW. Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance.Toxicology 2003;193(1-2):91-109.
9-Mitsuhashi M, Peel D, Ziogas A, Anton-Culver H. Enhanced expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. Biomarker Insights 2009;4:201-9.
10-Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 2001;29(9):e45.
11-Rødningen OK, Børresen-Dale AL, Alsner J, Hastie T, Overgaard J. Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol 2008;86(3):314-20.
12-Kasten-Pisula U, Vronskaja S, Overgaard J, Dikomey E. In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteins. Radiother Oncol 2008;86(3):321-8.
13-Paul S, Amundson SA. Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys 2008;71(4):1236-44.
14-Colón E, Reyes JS, González Keelan C, Climent-Peris C. Prevalence of steroied Receptors and HER-2/neu in breast cancer biopsies of women living in Puerto Rico. PR Health sci J 2002;21(4):299-303.
15-Benz CC, Thor AD, Eppenberger-Castori S, Eppenberger U, Moore D 3rd. Understanding the age dependency of breast cancer biomarkers. Adv Gerontol 2003;11:117-20.
16-Le Scodan R, Cizeron-Clairac G, Fourme E, Meseure D, Vacher S, Spyratos F, et al. DNA repair gene expression and risk of locoregional relapse in breast cancer patients. Int J Radiat Oncol Biol Phys 2010;78(2):328-36.
17-Djuzenova C, Mühl B, Schakowski R, Oppitz U, Flentje M. Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer 2004;90(12):2356-63.
18-Leong T, Chao M, Bassal S, McKay M. Radiation-hypersensitive cancer patients do not manifest protein expression abnormalities in components of the nonhomologous end-joining (NHEJ) pathway. Br J Cancer 2003;88(8):1251-5.
19-Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 2001;98(9):5134-9.
20-Saleh EM, El-Awady RA. Expression of RAD51, BRCA1 and P53 does not correlate with cellular radiosensitivity of normal human fibroblasts. Ir J Med Sci 2011;180(3):715-20.
21-Sak A, Stueben G, Groneberg M, Böcker W, Stuschke M. Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer 2005;92(6):1089-97.
22-Collis SJ, Tighe A, Scott SD, Roberts SA, Hendry JH, Margison GP. Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res 2001;29(7):1534-8.